DuBois City Finances Projected to End the Year “Cash Positive”

DuBois is on track to exceed its projected revenue while keeping spending far below budgeted estimates, according to city officials. Finance Administrator Angela Sangster shared these positive findings during a Wednesday City Council meeting, signaling a potential surplus by year’s end.

SK Hynix’s Stock Trades at Around 5 Times Next Year’s Earnings Even After Revenue Grew 257%. Here’s What a Multiple That Low Usually Signals About a Cyclical Business.

SK Hynix’s stock is trading at remarkably low levels—around five times next year’s earnings—even after revenue soared by 257%. The discrepancy underscores the memory chip sector’s vulnerability to sudden swings in market demand.

SK Hynix’s Stock Trades at Around 5 Times Next Year’s Earnings Even After Revenue Grew 257%. Here’s What a Multiple That Low Usually Signals About a Cyclical Business.

ADMA Biologics Reports Second Quarter 2026 Financial Results and Provides Business Update

ADMA Biologics reports $124.4 million in second-quarter revenue for 2026—a 2% increase year-over-year—and offers a brief business update. These figures point to modest yet steady growth in the current economic climate.

Ondas to Buy Autonomous Aircraft Maker DZYNE for $875.8 Million – Bloomberg.com

Ondas Holdings has announced plans to acquire autonomous aircraft maker DZYNE Technologies for $875.8 million, positioning itself as a growing force in defense technology. Financial reports suggest that this move could drive a significant revenue boost by 2026, establishing a powerful presence in aerial security and autonomous operations.

Esperion Therapeutics Closes Acquisition of Corstasis Therapeutics, Expanding Its Cardiovascular Franchise with EnbumystTM (bumetanide nasal spray)

Esperion Therapeutics has completed its acquisition of Corstasis Therapeutics, bringing the FDA-approved Enbumyst nasal spray into its cardiovascular portfolio. This first-in-class nasal spray loop diuretic helps manage fluid retention for congestive heart failure, marking a new step in Esperion’s plan to address the growing global burden of cardiometabolic disease. Executives anticipate that Enbumyst will bolster the company’s commercial capabilities and revenue growth.

Esperion Therapeutics Closes Acquisition of Corstasis Therapeutics, Expanding Its Cardiovascular Franchise with EnbumystTM (bumetanide nasal spray)

FitLife Brands Announces Fourth Quarter and Full-Year 2025 Results

FitLife Brands, a leading force in nutritional supplements, experienced a 73% jump in its fourth-quarter 2025 revenue compared to the previous year. Thanks to its recent acquisition of Irwin Naturals and strong wholesale growth, the Company posted solid gains, despite a decrease in gross margin and net income.

FitLife Brands Announces Fourth Quarter and Full-Year 2025 Results

Cambridge-Lee Reports Higher Revenue and Net Income in Q4 2025

Cambridge-Lee Holdings, Inc. recorded higher revenue and net income for the fourth quarter of 2025, attributable to increased sales and operating income. The Reading, Pennsylvania-based company released unaudited figures showing that stronger sales activities boosted its financial results.

Cambridge-Lee Reports Higher Revenue and Net Income in Q4 2025

EnerSys Posts $919M Quarter, Boosts Cash Flow, Backs Outlook

EnerSys posted third-quarter fiscal 2026 revenue of $919 million and reported modest overall growth. The Reading, Pennsylvania-based company also noted expanding margins (excluding federal manufacturing credits) and a surge in cash flow, reinforcing its confidence in the current corporate outlook.

EnerSys Posts $919M Quarter, Boosts Cash Flow, Backs Outlook

Epic Store saw record player count and 57% increase in third-party game sales in 2025, topping $400 million

Epic Games Store closed out 2025 with remarkable success by posting a 57% increase in third-party game revenue and a record of 78 million monthly active users. Time spent on third-party games rose by 4%, and total sales for these titles exceeded $400 million.

Epic Store saw record player count and 57% increase in third-party game sales in 2025, topping $400 million

One Apparel Legend Posted 8 Straight Beats While Its Rival Lost 74% in Five Years

Two apparel giants, Levi Strauss and VF Corporation, just released financial results that reveal starkly different fortunes. Levi has posted eight consecutive strong quarters, while VF faces long-term challenges, including a reported 74% decline over five years.